| Ipsen Pharma Schweiz GmbH - Cabometyx 40 mg, Filmtabletten | | 66471 | | 02 | | Cabometyx 40 mg | | Filmtabletten | | L01EX07 | | Cabozantinib | | 15.12.2017 | | |
| | Composition | | cabozantinibum 40 mg ut cabozantinibi l-malas 50.69 mg, cellulosum microcristallinum, lactosum 31.07 mg, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 1.8 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Cabozantinibum | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Cabozantinibum | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactosum | 31.07 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 | 4670.20 | 5037.85 | A | LS | Oui |
|
|
